The role of radiation therapy in the management of non-metastatic Ewing's sarcoma of bone. Report of the Intergroup Ewing's Sarcoma Study. 1981

C A Perez, and M Tefft, and M Nesbit, and E O Burgert, and T Vietti, and J Kissane, and D J Pritchard, and E A Gehan

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D011879 Radiotherapy Dosage The total amount of radiation absorbed by tissues as a result of radiotherapy. Dosage, Radiotherapy,Dosages, Radiotherapy,Radiotherapy Dosages
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D001859 Bone Neoplasms Tumors or cancer located in bone tissue or specific BONES. Bone Cancer,Cancer of Bone,Cancer of the Bone,Neoplasms, Bone,Bone Neoplasm,Neoplasm, Bone
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D003609 Dactinomycin A compound composed of a two CYCLIC PEPTIDES attached to a phenoxazine that is derived from STREPTOMYCES parvullus. It binds to DNA and inhibits RNA synthesis (transcription), with chain elongation more sensitive than initiation, termination, or release. As a result of impaired mRNA production, protein synthesis also declines after dactinomycin therapy. (From AMA Drug Evaluations Annual, 1993, p2015) Actinomycin,Actinomycin D,Meractinomycin,Cosmegen,Cosmegen Lyovac,Lyovac-Cosmegen,Lyovac Cosmegen,Lyovac, Cosmegen,LyovacCosmegen

Related Publications

C A Perez, and M Tefft, and M Nesbit, and E O Burgert, and T Vietti, and J Kissane, and D J Pritchard, and E A Gehan
April 1981, National Cancer Institute monograph,
C A Perez, and M Tefft, and M Nesbit, and E O Burgert, and T Vietti, and J Kissane, and D J Pritchard, and E A Gehan
September 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
C A Perez, and M Tefft, and M Nesbit, and E O Burgert, and T Vietti, and J Kissane, and D J Pritchard, and E A Gehan
March 1983, Cancer,
C A Perez, and M Tefft, and M Nesbit, and E O Burgert, and T Vietti, and J Kissane, and D J Pritchard, and E A Gehan
September 1983, Human pathology,
C A Perez, and M Tefft, and M Nesbit, and E O Burgert, and T Vietti, and J Kissane, and D J Pritchard, and E A Gehan
January 1982, The American journal of pediatric hematology/oncology,
C A Perez, and M Tefft, and M Nesbit, and E O Burgert, and T Vietti, and J Kissane, and D J Pritchard, and E A Gehan
September 1990, Cancer,
C A Perez, and M Tefft, and M Nesbit, and E O Burgert, and T Vietti, and J Kissane, and D J Pritchard, and E A Gehan
March 1993, Cancer,
C A Perez, and M Tefft, and M Nesbit, and E O Burgert, and T Vietti, and J Kissane, and D J Pritchard, and E A Gehan
July 2020, Ideggyogyaszati szemle,
C A Perez, and M Tefft, and M Nesbit, and E O Burgert, and T Vietti, and J Kissane, and D J Pritchard, and E A Gehan
August 1970, Strahlentherapie,
C A Perez, and M Tefft, and M Nesbit, and E O Burgert, and T Vietti, and J Kissane, and D J Pritchard, and E A Gehan
July 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Copied contents to your clipboard!